Stock Events

Stock Events

Myomo 

€0.57
63
-€0.01-1.22% Thursday 06:16

Statistics

Day High
0.55
Day Low
0.55
52W High
4.49
52W Low
0.55
Volume
-
Avg. Volume
-
Mkt Cap
21.87M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.11
-0.08
-0.04
-0.01
Expected EPS
-0.114
Actual EPS
N/A

Financials

-18.9%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
61.87MRevenue
-11.69MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0M61.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Ekso Bionics
EKSO
Mkt Cap33.5M
Ekso Bionics designs and manufactures powered exoskeletons which can be used for rehabilitation and mobility, directly competing with Myomo's mobility enhancement devices.
Resmed
RMD
Mkt Cap32.71B
ResMed is known for its products in the sleep and respiratory markets but also offers devices that can improve quality of life, indirectly competing with Myomo's focus on enhancing mobility.
Hologic
HOLX
Mkt Cap16.89B
Hologic, primarily focused on women's health, also develops medical devices that can compete indirectly with Myomo by offering diagnostic and treatment solutions in overlapping healthcare markets.
Smith & Nephew
SNN
Mkt Cap13.72B
Smith & Nephew specializes in orthopedics, including robotics and digital solutions for surgery, which can indirectly compete with Myomo's orthotic devices by offering alternative treatments and rehabilitation methods.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare, including products for joint reconstruction which can indirectly compete with Myomo's solutions for mobility and rehabilitation.
Medtronic
MDT
Mkt Cap111.22B
Medtronic plc offers a wide range of medical devices and therapies, including those for spinal and musculoskeletal conditions, indirectly competing with Myomo's assistive technologies.
Stryker
SYK
Mkt Cap126.97B
Stryker Corporation specializes in medical and surgical equipment, including neurotechnology and spine products, which can indirectly compete with Myomo's focus on enhancing mobility through technology.
Globus Medical
GMED
Mkt Cap11.89B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spine and orthopedic devices, indirectly competing with Myomo by offering alternative treatments for mobility impairments.

About

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Show more...
CEO
Country
DE
ISIN
US62857J2015
WKN
000A2PZCL

Listings

F
DE
0M61.F
XASE
US
MYO
BOATS
BOATS
MYO.BOATS

0 Comments

Share your thoughts

FAQ

What is Myomo stock price today?▼
The current price of 0M61.F is €0.57 EUR — it has decreased by -1.22% in the past 24 hours. Watch Myomo stock price performance more closely on the chart.
What is Myomo stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Myomo stocks are traded under the ticker 0M61.F.
Is Myomo stock price growing?▼
0M61.F stock has fallen by -3.56% compared to the previous week, the month change is a -20.86% fall, over the last year Myomo has showed a -86.29% decrease.
What is Myomo market cap?▼
Today Myomo has the market capitalization of 21.87M
When is the next Myomo earnings date?▼
Myomo is going to release the next earnings report on May 13, 2026.
What were Myomo earnings last quarter?▼
0M61.F earnings for the last quarter are -0.08 EUR per share, whereas the estimation was -0.07 EUR resulting in a -4.65% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Myomo revenue for the last year?▼
Myomo revenue for the last year amounts to 61.87M EUR.
What is Myomo net income for the last year?▼
0M61.F net income for the last year is -11.69M EUR.
When did Myomo complete a stock split?▼
Myomo has not had any recent stock splits.